What is Ravi Nemivant's NPI number?

Ravi Nemivant's National Provider Identifier (NPI) is 1003883463, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ravi Nemivant's specialty?

Ravi Nemivant is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Ravi Nemivant located?

Ravi Nemivant's practice location on file with NPPES is 100 Spalding Dr, Naperville, IL 60540-6550.

What is Ravi Nemivant's phone number?

The practice phone number listed in the NPPES registry for Ravi Nemivant is (630) 871-6699.

Does Ravi Nemivant accept Medicare?

Ravi Nemivant is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ravi Nemivant's NPI active?

Yes — Ravi Nemivant's NPI (1003883463) is active in the NPPES registry as of the last update on 2023-08-16.

IndividualActiveAccepts Medicare

Ravi Nemivant, MD

NPI 1003883463 · Pulmonary Disease Physician · Naperville, IL

Ravi Nemivant, MD is a Pulmonary Disease Physician provider in Naperville, IL (NPI 1003883463).

Provider details

NPI number: 1003883463
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 036104366 (IL)

Practice location

100 Spalding Dr

Ste 102

Naperville, IL 60540-6550

Phone: (630) 871-6699

Street-level locationGet directions

More IL providers

Mailing address

Po Box 713260

Chicago, IL 60677-1260

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense 036104366 (IL)
Allopathic & Osteopathic Physicians
Sleep Medicine (Internal Medicine) Physician207RS0012XLicense 036104366 (IL)
Allopathic & Osteopathic Physicians
Critical Care Medicine (Internal Medicine) Physician207RC0200XLicense 036104366 (IL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(86/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,865 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	268	$130
Test to Examine How Well the Lungs Exchange Gases94729	212	$58
Test to Determine Lung Volumes Using Sensors94726	211	$57
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	132	$185
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	131	$17
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	110	39
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	102	43
Fluticasone/Vilanterolbrand: Breo Ellipta	94	31
Fluticasone Propion/Salmeterolbrand: Wixela Inhub	57	30
Montelukast Sodium	57	20
Prednisone	57	37

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$49 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-03-03
Last updated: 2023-08-16
Certified: 2023-08-16

Frequently asked questions

What is Ravi Nemivant's NPI number?: Ravi Nemivant's National Provider Identifier (NPI) is 1003883463, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ravi Nemivant's specialty?: Ravi Nemivant is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Ravi Nemivant located?: Ravi Nemivant's practice location on file with NPPES is 100 Spalding Dr, Naperville, IL 60540-6550.
What is Ravi Nemivant's phone number?: The practice phone number listed in the NPPES registry for Ravi Nemivant is (630) 871-6699.
Does Ravi Nemivant accept Medicare?: Ravi Nemivant is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ravi Nemivant's NPI active?: Yes — Ravi Nemivant's NPI (1003883463) is active in the NPPES registry as of the last update on 2023-08-16.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	268	$130
Test to Examine How Well the Lungs Exchange Gases94729	212	$58
Test to Determine Lung Volumes Using Sensors94726	211	$57
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	132	$185
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	131	$17
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	110	39
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	102	43
Fluticasone/Vilanterolbrand: Breo Ellipta	94	31
Fluticasone Propion/Salmeterolbrand: Wixela Inhub	57	30
Montelukast Sodium	57	20
Prednisone	57	37

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$49 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments